Laboratory Evaluation for Vasculitis Causing Recurrent Strokes
A comprehensive laboratory workup for suspected vasculitis causing recurrent strokes should include erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), complete blood count, ANCA testing (both immunofluorescence and ELISA for PR3 and MPO), and cerebrospinal fluid analysis. 1, 2
First-Line Laboratory Tests
Inflammatory Markers
- ESR and CRP: Essential baseline inflammatory markers, though non-specific 2
- Complete blood count: To assess for anemia, leukocytosis, or eosinophilia (particularly important in certain vasculitides) 1, 2
Autoimmune Markers
- ANCA testing:
- Both immunofluorescence (to detect cytoplasmic or perinuclear pattern) and ELISA (for PR3 and MPO specificity) 1, 2
- The 2017 revised consensus recommends high-quality antigen-specific immunoassays as the preferred screening methodology 2
- ANCA subtypes (PR3-ANCA and MPO-ANCA) correlate with different clinical presentations 2
Renal Function Assessment
- Serum creatinine: To evaluate renal involvement 1
- Urinalysis: For microscopic hematuria, proteinuria, and casts 1
Second-Line Laboratory Tests
Additional Autoimmune Markers
- Rheumatoid factor
- Antinuclear antibody (ANA)
- Anti-DNA antibody
- Anti-Ro/SSA and La/SSB antibodies
- Anti-glomerular basement membrane (GBM) antibodies 2, 3
Coagulation Studies
- Anticardiolipin antibody
- Lupus anticoagulant 3
Immunological Tests
- Complement levels (C3, C4, CH50)
- Immunoglobulin levels
- Cryoglobulins 2
Infectious Disease Screening
- Hepatitis B and C serology: Particularly important for polyarteritis nodosa and cryoglobulinemic vasculitis 1, 2
- HIV testing: Due to high coexistence with certain vasculitides 1
- Consider specific infectious agents: VZV, syphilis, tuberculosis based on clinical suspicion 1, 4
Cerebrospinal Fluid Analysis
- Cell count and differential: Look for lymphocytic pleocytosis
- Protein levels: Often elevated in CNS vasculitis
- Specific antibody testing: Anti-VZV IgG has highest sensitivity for VZV vasculitis 1
Important Considerations
Targeted screening approach: Evidence suggests that universal vasculitis screening in all young stroke patients has a low yield (only 2% positive in one study) 3. Testing should be guided by clinical suspicion based on:
- Recurrent strokes despite standard therapy
- Fever of unknown origin
- Multifocal neurological events
- Unexplained skin lesions
- Glomerulopathy
- Elevated inflammatory markers 1
Interpretation challenges: ESR and CRP are non-specific and don't distinguish between vasculitis activity and concurrent infection 2, 5
ANCA monitoring limitations: While ANCA antibodies may predict poor prognosis in some patients, their use in monitoring disease activity has minor importance 5
Common pitfall: Relying solely on laboratory tests without clinical correlation. The diagnosis of vasculitis requires integration of clinical, laboratory, and imaging findings 1
Expert consultation: Given the complexity of diagnosis, patients with suspected vasculitis should be managed in collaboration with centers of expertise 1
Remember that a definitive diagnosis often requires tissue biopsy showing typical features of vasculitis, though this may not always be feasible for CNS vasculitis 1.